Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies
Artificial IntelligenceThis is a pragmatic, double-blind, randomized, controlled trial, to evaluate the effect of implementing a Computer-assisted detection (CADe) system within the routine clinical practice of Canadian healthcare institutions.
The main hypothesis of this study is that the ADR in the operating room equipped with the GI genius CADe system will be significantly higher than the ADR in the ordinary operating room.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
45 to 89
Participation Criteria
Inclusion Criteria:
* indication of undergoing a screening, surveillance, or diagnostic colonoscopy
* Age 45-89 years
Exclusion Criteria:
* Patients undergoing emergency colonoscopy
* Patients with a known familial polyposis syndrome or a known inflammatory bowel disease
Study Location
Centre Hospitalier Universitaire de Montréal
Centre Hospitalier Universitaire de MontréalMontréal, Quebec
Canada
Contact Study Team
Daniel von Renteln, MD
Centre Hospitalier Universitaire de Montréal
Centre Hospitalier Universitaire de MontréalMontreal, Quebec
Canada
Contact Study Team
- Study Sponsored By
- Centre hospitalier de l'Université de Montréal (CHUM)
- Participants Required
- More Information
- Study ID:
NCT05244278